Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-fat meal effect on pharmacokinetics of DO-2 in healthy subjects
NL-OMON59046Phase 1Completed
- Sponsor
- DeuterOncology
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of do-2, sponsored by DeuterOncology. Primary endpoint: Primary endpoint(s). Started Dec 2024; status: completed.
02
Drugs
do-2
Beyond the preview
Go deeper on NL-OMON59046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59046.